Fifth Annual PRECEDE Meeting and inaugural AI Summit in NYC
ClearNote Health Joins the PRECEDE Consortium in New Partnership to Reduce Cancer Mortality
Biological Dynamics and PRECEDE Collaborate to Improve Surveillance of Early Pancreatic Cancer
PRECEDE enrolled over 5000 participants
Enrolled over 4000 participants!
Fourth Annual PRECEDE Consortium Meeting in NYC and inaugural Biomarker Summit
Over 3000 participants are enrolled in PRECEDE
Third Annual PRECEDE Consortium Meeting in NYC
PRECEDE Consortium Announces Konica Minolta Precision Medicine as its Precision Health Partner to Advance its Mission to Increase Survival Rates for Patients with Pancreatic Cancer
Greater than 1000 participants enrolled in PRECEDE
Second Annual PRECEDE Consortium Meeting, virtual
First participant enrolled in PRECEDE
PRECEDE study protocol approved by sIRB
First Annual PRECEDE Consortium Meeting in NYC
Pancreatic Cancer Early Detection Research Consortium (PRECEDE) name is adopted
Project Purple and IMPACT PDA International Consortium execute contract with Arbor Research for build of electronic data collection platform, biosample labeling and tracking, and site onboarding for the first 25 clinical sites
Project Purple announces $1.25 million dollar gift to support early detection research
First “Early Detection Collaboration Meeting”